Talk:Cripto
Add topic | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||
| |||||||||||||||||
Untitled
[edit]It is necessary to understand the literature using the term crypto-1, since both pages Cripto (CFC1B gene) and Teratocarcinoma-derived growth factor 1 (TDGF1 gene) refer to literature using the same term crypto-1. For example link in this article: Liu Y, Qin Z, Yang K, Liu R, Xu Y (March 2017). "Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/β-catenin signaling". Oncology Reports. 37 (3): 1521–1528. doi:10.3892/or.2017.5378. PMID 28098905 it is about CR-1 (Teratocarcinoma derived growth factor 1)
also in == Clinical significance == text is about CFC1B gene, but the link is given to Park KS, Raffeld M, Moon YW, Xi L, Bianco C, Pham T, et al. (July 2014). "CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance". The Journal of Clinical Investigation. 124 (7): 3003–15. doi:10.1172/JCI73048. PMC 4071378. PMID 24911146. ("CRIPTO1, also known as teratocarcinoma-derived growth factor 1 (TDGF1)" Dmitry Dzhagarov (talk) 12:23, 12 September 2021 (UTC)